OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 78 filers reported holding OLEMA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $52,609 | +52.1% | 15,161 | +7.4% | 0.00% | – |
| Q4 2022 | $34,594 | -66.4% | 14,120 | -62.2% | 0.00% | -100.0% |
| Q3 2022 | $103,000 | -63.2% | 37,314 | -45.7% | 0.00% | -50.0% |
| Q2 2022 | $280,000 | -30.3% | 68,735 | -27.1% | 0.00% | -33.3% |
| Q1 2022 | $402,000 | -49.6% | 94,290 | +10.7% | 0.00% | -62.5% |
| Q4 2021 | $797,000 | -30.9% | 85,198 | +103.7% | 0.01% | -46.7% |
| Q3 2021 | $1,153,000 | +1821.7% | 41,832 | +1845.7% | 0.02% | +1400.0% |
| Q2 2021 | $60,000 | – | 2,150 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 3,743,875 | $180,006,000 | 15.43% |
| BVF INC/IL | 6,661,503 | $320,285,000 | 12.60% |
| VR Adviser, LLC | 1,536,193 | $73,860,000 | 10.86% |
| Foresite Capital Management IV, LLC | 818,030 | $39,331,000 | 4.27% |
| Cormorant Asset Management, LP | 3,195,544 | $148,169,000 | 3.53% |
| Vivo Capital, LLC | 1,238,575 | $59,551,000 | 2.66% |
| RA Capital Management | 2,150,404 | $103,391,000 | 1.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 696,191 | $33,473,000 | 0.66% |
| Avoro Capital Advisors LLC | 876,986 | $35,646,000 | 0.61% |
| Avidity Partners Management LP | 270,000 | $12,982,000 | 0.42% |